Sign In
Buy FLGT
$16.55
-3.66 (-18.11%)
At Close: Jul 31, 2026
Dow Jones Today, Stocks Advance As Active Covid-19 Cases Hit Record; Apple Opens NY Stores; Chegg Leads IBD 50
01:49pm, Wednesday, 17'th Jun 2020
Chegg and biotech Fulgent Genetics outran rising stock futures Wednesday, Apple led the Dow Jones today, even as coronavirus data took a worrying turn.
Fulgent Pops 18% In After-Market On FDA Nod For Covid-19 Home Test
07:05am, Wednesday, 17'th Jun 2020
Fulgent Genetics Inc. (FLGT) said it was granted Emergency Use Authorization (EUA) for its Covid-19 home testing kit by the US Food and Drug
Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19 | MarketScreener
08:06pm, Tuesday, 16'th Jun 2020Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19
08:05pm, Tuesday, 16'th Jun 2020
The company has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for use in the United States. Fulgent Genetics will be offering the testing service through P
Fulgent's COVID-19 Tests Are Ramping Fast, But Their Other Tests Are Suffering (NASDAQ:FLGT)
10:11pm, Wednesday, 10'th Jun 2020
The company's strong growth is likely to suffer as a result of the pandemic, but we think this is only a temporary blip. The company rapidly adjusted and develo
Edited Transcript of FLGT earnings conference call or presentation 4-May-20 8:30pm GMT
06:32am, Friday, 22'nd May 2020
Q1 2020 Fulgent Genetics Inc Earnings Call
The company is offering end-to-end processing, analysis and reporting for its COVID-19 tests through its BSL-2, CLIA-certified lab in Temple City, California. In addition, the EUA allows for the test
Fulgent Genetics, Inc. (FLGT) Q1 2020 Earnings Call Transcript
03:00pm, Tuesday, 05'th May 2020
On the call today, we have Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer. The company's press release discussing its financial
Fulgent Genetics Reports First Quarter 2020 Financial Results | MarketScreener
08:06pm, Monday, 04'th May 2020Fulgent Genetics Reports First Quarter 2020 Financial Results
08:05pm, Monday, 04'th May 2020
First Quarter 2020 Results: Revenue totals $7.8 million, growing 44% year over yearBillable tests delivered total 13,163, growing 75% year over yearGross Margin improves.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Quest Diagnostics (DGX) Receives a Hold from Credit Suisse
07:42pm, Friday, 24'th Apr 2020
Credit Suisse analyst Erin Wright maintained a Hold rating on Quest Diagnostics (DGX) yesterday and set a price target of $100.00. The company's shares
Quest Diagnostics (DGX) Receives a Hold from Credit Suisse
07:42pm, Friday, 24'th Apr 2020
Credit Suisse analyst
Erin Wright
maintained a
Hold
rating on Quest Diagnostics (
DGX
–
Research Report
) yesterday and set a price target of
$100.00
. The company’s shares closed last Friday at $
Credit Suisse Maintains a Hold Rating on Covetrus (CVET)
01:16pm, Thursday, 23'rd Apr 2020
In a report released today, Erin Wright from Credit Suisse maintained a Hold rating on Covetrus (CVET), with a price target of $10.00. The company's
